ESC 365 - How effective is revascularisation for angina? Lessons learnt from the ORBITA trials

ESC Professional Premium Access

How effective is revascularisation for angina? Lessons learnt from the ORBITA trials

Session: Treatment of angina in chronic coronary syndromes: where do we stand?

Topic: Treatment

Speaker: Doctor J. Tamis-Holland (Cleveland, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Jacqueline Tamis-Holland

Cleveland Clinic, Cleveland (United States of America)

4 presentations

1 follower

4 more presentations in this session

How effective are medications for angina?

Speaker: Professor P. Steg (Paris, FR)

What is the burden and clinical impact of residual angina?

Speaker: Professor E. Navarese (Sassari, IT)

Therapeutic options beyond medications and revascularisation

Speaker: Professor T. Luescher (London, GB)

Treatment of angina in chronic coronary syndromes: where do we stand? - discussion

Access the full session

Treatment of angina in chronic coronary syndromes: where do we stand?

Speakers: Doctor J. Tamis-Holland, Professor P. Steg, Professor E. Navarese, Professor T. Luescher

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources